Download PDF
1 / Pages

Other users also viewed these articles

Respiratory syncytial virus infections requiring hospitalization in patients with primary immunodeficiency Luis Ignacio González-Granado; Andrea Martín-Nalda; Laia Alsina; Olaf Neth; Manuel Santamaría; Pere Soler-Palacín;
An Pediatr (Barc). 2022;96:492-500
Nirsevimab for the prevention of respiratory syncytial virus disease in children. Statement of the Spanish Society of Paediatric Infectious Disease (SEIP) Laura Francisco; Marta Cruz-Cañete; Carlos Pérez; José Antonio Couceiro; Enrique Otheo; Cristian Launes; Carlos Rodrigo; Ana Belén Jiménez; Marta Llorente; Abián Montesdeoca; José Rumbao; Cristina Calvo; Susana Frago; Alfredo Tagarro;
An Pediatr (Barc). 2023;99:257-63
Decrease in the use of bronchodilators in the management of bronchiolitis after applying improvement initiatives David Andina Martínez; Silvia Escalada Pellitero; Pedro Viaño Nogueira; Jose Antonio Alonso Cadenas; María José Martín Díaz; Mercedes de la Torre-Espi; Raquel Jiménez García;
An Pediatr (Barc). 2022;96:476-84